Chief Investor Relations & Corporate Communications

Initial Therapeutics, Inc.

South San Francisco (CA)

On-site

USD 309,000 - 381,000

Full time

14 days+
Application generator

Turn this role into an interview — a resume and cover letter built around what this employer wants.

Get past ATS filters

Benefits offered by this job

Health benefits
401k
ESPP
Wellness programs

Job summary

IDEAYA Biosciences is seeking a Vice President, Investor Relations & Corporate Communications in South San Francisco, CA. This leader will build and run an integrated IR and corporate communications function during a pivotal growth phase toward commercialization.

The role reports to the CFO and works with the CEO and leadership team to shape external messaging, investor engagement, and communications infrastructure.

Qualifications

  • 15+ years of progressive leadership experience in investor relations, corporate communications, equity research, or related biotech roles.
  • Significant experience supporting publicly traded biotechnology companies.
  • Strong understanding of biotechnology drug development, clinical development, regulatory pathways, and capital markets.
  • Demonstrated success building trusted relationships with institutional investors, analysts, media, executives, and Boards.
  • Experience leading communications around clinical, regulatory, financing, and strategic milestones.

Responsibilities

  • Develop and execute a comprehensive investor relations strategy aligned with IDEAYA's objectives.
  • Serve as a key contact for institutional investors and analysts.
  • Prepare for quarterly earnings, roadshows, and investor meetings; develop earnings materials and messaging.
  • Oversee press releases, investor materials, and executive talking points.
  • Monitor investor sentiment and ensure SEC disclosure compliance and governance standards.
  • Develop and execute corporate communications strategy to strengthen reputation and visibility.
  • Lead and scale the Investor Relations and Corporate Communications function, including hiring and processes.

Skills

Investor relations
Corporate communications
Stakeholder engagement
Public speaking
Strategic thinking
Leadership
Cross-functional collaboration

Education

Bachelor's degree in Finance, Business, Communications, Life Sciences
MBA or advanced scientific degree preferred

Job description

IDEAYA Biosciences is seeking a Vice President, Investor Relations & Corporate Communications in South San Francisco, CA. This leader will build and run an integrated IR and corporate communications function during a pivotal growth phase toward commercialization.

The role reports to the CFO and works with the CEO and leadership team to shape external messaging, investor engagement, and communications infrastructure.

Get your free, confidential resume review.

or drag and drop your file here.

Similar jobs

Similar jobs worth comparing

VP, Investor Relations & Corporate Communications
VP, Investor Relations & Corporate Communications

IDEAYA Biosciences, Inc. • South San Francisco (CA)

On-site
USD 309,000 - 381,000
Medical coverage
Dental coverage
Vision coverage
+4
VP, IR & Corporate Communications — Storytelling & Growth
VP, IR & Corporate Communications — Storytelling & Growth

IDEAYA • South San Francisco (CA)

On-site
USD 309,000 - 381,000
Vice President, Investor Relations & Corporate Communications
Vice President, Investor Relations & Corporate Communications

IDEAYA Biosciences, Inc. • South San Francisco (CA)

On-site
USD 309,000 - 381,000
Medical coverage
Dental coverage
Vision coverage
+4
Vice President, Investor Relations & Corporate Communications
Vice President, Investor Relations & Corporate Communications

Initial Therapeutics, Inc. • South San Francisco (CA)

On-site
USD 309,000 - 381,000
Health benefits
401k
ESPP
+1
Vice President, Investor Relations & Corporate Communications
Vice President, Investor Relations & Corporate Communications

IDEAYA • South San Francisco (CA)

On-site
USD 309,000 - 381,000
Investor Relations & Corporate Communications Director Hybrid Equity
Investor Relations & Corporate Communications Director Hybrid Equity

Lyell Immunopharma, Inc. • South San Francisco (CA)

Hybrid
USD 220,000 - 300,000
Equity Incentive Plan
Annual bonus
Investor Relations & Corporate Communications Lead
Investor Relations & Corporate Communications Lead

Iovance Biotherapeutics • Philadelphia

On-site
USD 120,000 - 170,000
Biotech VP: Investor Relations & Scientific Communications
Biotech VP: Investor Relations & Scientific Communications

Kennedy Bond • San Francisco (CA)

On-site
USD 250,000 - 500,000
Senior Manager, SEC Reporting & Technical Accounting
Senior Manager, SEC Reporting & Technical Accounting

BioSpace • South San Francisco (CA)

On-site
USD 162,000 - 200,000
Medical/Dental/Vision coverage
401k and ESPP
Wellness programs
Senior Manager, SEC Reporting & Technical Accounting
Senior Manager, SEC Reporting & Technical Accounting

Initial Therapeutics, Inc. • South San Francisco (CA)

On-site
USD 162,000 - 200,000
Medical/dental/vision coverage
401k
ESPP
+1